I'm guessing institutions are running the stops to scoop more shares. The mkt cap is now just under $2 billion, yet a reasonable analysis shows for the 3 indications (Parkinson's, Alzheimers, Schizophrenia) that net to ACAD would be about $20B/year. So this market cap makes no sense whatsoever. I'm guessing there's a large number of Cramer lemmings who are taking advantage of the bounce from $20 to cashout out before it hits $20 again. I don't think it'll get there. I think the retest of that low, on lower volume, just happened. The market will frustrate the maximum number investors, is the best trading advice I've found over the years.
its your call...was up huge...and took some...the question really is...if wat u say is true...y aren't u selling???
the road of biotech is littered with shattered dreams...but hey..if u want to swing for the fences...go for it...good luck